Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Open Access
- 1 October 2014
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 168 (4) , 487-494
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Outcomes registry for better informed treatment of atrial fibrillation: Rationale and design of ORBIT-AFAmerican Heart Journal, 2011
- Warfarin Discontinuation After Starting Warfarin for Atrial FibrillationCirculation: Cardiovascular Quality and Outcomes, 2010
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based ApproachChest, 2010
- Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?Journal of Thrombosis and Haemostasis, 2008
- Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial FibrillationCirculation, 2007
- Validation of Clinical Classification Schemes for Predicting StrokeJAMA, 2001
- Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trialThe Lancet, 1996
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991
- Stroke Prevention in Atrial Fibrillation Study. Final results.Circulation, 1991
- Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy.Circulation, 1991